Antibodies to β1 and β2 adrenoreceptors in Chagas' disease

Evidence accumulated over the last decade concerning human and experimental models suggests that an immunopathological mechanism may be involved in the pathogenesis of chronic Chagas' disease. In this paper we demonstrate the existence of two different circulating IgG in chagasic patients which...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 1988
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00099104_v74_n3_p349_SterinBorda
http://hdl.handle.net/20.500.12110/paper_00099104_v74_n3_p349_SterinBorda
Aporte de:
id paper:paper_00099104_v74_n3_p349_SterinBorda
record_format dspace
spelling paper:paper_00099104_v74_n3_p349_SterinBorda2023-06-08T14:34:09Z Antibodies to β1 and β2 adrenoreceptors in Chagas' disease beta 1 adrenergic receptor beta 2 adrenergic receptor cyclic amp dihydroalprenolol immunoglobulin g isoprenaline propranolol receptor antibody chagas disease clinical article human priority journal protozoon Antibody Specificity Chagas Cardiomyopathy Cyclic AMP Dihydroalprenolol Dose-Response Relationship, Immunologic Human Immunoglobulin G Immunoglobulins, Fab Lymphocytes Myocardium Receptors, Adrenergic, beta Spleen Time Factors Evidence accumulated over the last decade concerning human and experimental models suggests that an immunopathological mechanism may be involved in the pathogenesis of chronic Chagas' disease. In this paper we demonstrate the existence of two different circulating IgG in chagasic patients which bind with myocardial β1 and spleen cell β2 adrenoceptors, acting as non-competitive inhibitors. Both chagasic IgG against β1 and β2 adrenoceptor increased intracellular levels of cAMP that could be blocked by specific β1 and β2 adrenoceptor antagonist. The specificity for β1 and β2 adrenoceptors and the independence of other tissue reactive antibodies was demonstrated by IgG absorption with turkey red blood cell (TRBC), human lymphocytes (HL) or guinea pig red blood cells (GPRBC). The F(ab')2 fraction acted similarly. This supports the specificity of β1 and β2 adrenoceptors to the chagasic IgG and the independence of the other tissue reactive antibodies, such as EVI system. The probable pathogenic role of both β1 and β2 adrenergic chagasic antibody is discussed. 1988 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00099104_v74_n3_p349_SterinBorda http://hdl.handle.net/20.500.12110/paper_00099104_v74_n3_p349_SterinBorda
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic beta 1 adrenergic receptor
beta 2 adrenergic receptor
cyclic amp
dihydroalprenolol
immunoglobulin g
isoprenaline
propranolol
receptor antibody
chagas disease
clinical article
human
priority journal
protozoon
Antibody Specificity
Chagas Cardiomyopathy
Cyclic AMP
Dihydroalprenolol
Dose-Response Relationship, Immunologic
Human
Immunoglobulin G
Immunoglobulins, Fab
Lymphocytes
Myocardium
Receptors, Adrenergic, beta
Spleen
Time Factors
spellingShingle beta 1 adrenergic receptor
beta 2 adrenergic receptor
cyclic amp
dihydroalprenolol
immunoglobulin g
isoprenaline
propranolol
receptor antibody
chagas disease
clinical article
human
priority journal
protozoon
Antibody Specificity
Chagas Cardiomyopathy
Cyclic AMP
Dihydroalprenolol
Dose-Response Relationship, Immunologic
Human
Immunoglobulin G
Immunoglobulins, Fab
Lymphocytes
Myocardium
Receptors, Adrenergic, beta
Spleen
Time Factors
Antibodies to β1 and β2 adrenoreceptors in Chagas' disease
topic_facet beta 1 adrenergic receptor
beta 2 adrenergic receptor
cyclic amp
dihydroalprenolol
immunoglobulin g
isoprenaline
propranolol
receptor antibody
chagas disease
clinical article
human
priority journal
protozoon
Antibody Specificity
Chagas Cardiomyopathy
Cyclic AMP
Dihydroalprenolol
Dose-Response Relationship, Immunologic
Human
Immunoglobulin G
Immunoglobulins, Fab
Lymphocytes
Myocardium
Receptors, Adrenergic, beta
Spleen
Time Factors
description Evidence accumulated over the last decade concerning human and experimental models suggests that an immunopathological mechanism may be involved in the pathogenesis of chronic Chagas' disease. In this paper we demonstrate the existence of two different circulating IgG in chagasic patients which bind with myocardial β1 and spleen cell β2 adrenoceptors, acting as non-competitive inhibitors. Both chagasic IgG against β1 and β2 adrenoceptor increased intracellular levels of cAMP that could be blocked by specific β1 and β2 adrenoceptor antagonist. The specificity for β1 and β2 adrenoceptors and the independence of other tissue reactive antibodies was demonstrated by IgG absorption with turkey red blood cell (TRBC), human lymphocytes (HL) or guinea pig red blood cells (GPRBC). The F(ab')2 fraction acted similarly. This supports the specificity of β1 and β2 adrenoceptors to the chagasic IgG and the independence of the other tissue reactive antibodies, such as EVI system. The probable pathogenic role of both β1 and β2 adrenergic chagasic antibody is discussed.
title Antibodies to β1 and β2 adrenoreceptors in Chagas' disease
title_short Antibodies to β1 and β2 adrenoreceptors in Chagas' disease
title_full Antibodies to β1 and β2 adrenoreceptors in Chagas' disease
title_fullStr Antibodies to β1 and β2 adrenoreceptors in Chagas' disease
title_full_unstemmed Antibodies to β1 and β2 adrenoreceptors in Chagas' disease
title_sort antibodies to β1 and β2 adrenoreceptors in chagas' disease
publishDate 1988
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00099104_v74_n3_p349_SterinBorda
http://hdl.handle.net/20.500.12110/paper_00099104_v74_n3_p349_SterinBorda
_version_ 1768544021934768128